165 related articles for article (PubMed ID: 11992559)
1. Pharmacogenetics of lithium prophylaxis in mood disorders: analysis of COMT, MAO-A, and Gbeta3 variants.
Serretti A; Lorenzi C; Lilli R; Mandelli L; Pirovano A; Smeraldi E
Am J Med Genet; 2002 May; 114(4):370-9. PubMed ID: 11992559
[TBL] [Abstract][Full Text] [Related]
2. Association study of MAO-A, COMT, 5-HT2A, DRD2, and DRD4 polymorphisms with illness time course in mood disorders.
Cusin C; Serretti A; Lattuada E; Lilli R; Lorenzi C; Smeraldi E
Am J Med Genet; 2002 May; 114(4):380-90. PubMed ID: 11992560
[TBL] [Abstract][Full Text] [Related]
3. Catechol-O-methyltransferase gene variants in mood disorders in the Italian population.
Serretti A; Rotondo A; Lorenzi C; Smeraldi E; Cassano GB
Psychiatr Genet; 2006 Oct; 16(5):181-2. PubMed ID: 16969269
[TBL] [Abstract][Full Text] [Related]
4. Further evidence for a possible association between serotonin transporter gene and lithium prophylaxis in mood disorders.
Serretti A; Malitas PN; Mandelli L; Lorenzi C; Ploia C; Alevizos B; Nikolaou C; Boufidou F; Christodoulou GN; Smeraldi E
Pharmacogenomics J; 2004; 4(4):267-73. PubMed ID: 15111989
[TBL] [Abstract][Full Text] [Related]
5. Family-based association study of 5-HTTLPR, TPH, MAO-A, and DRD4 polymorphisms in mood disorders.
Serretti A; Cristina S; Lilli R; Cusin C; Lattuada E; Lorenzi C; Corradi B; Grieco G; Costa A; Santorelli F; Barale F; Nappi G; Smeraldi E
Am J Med Genet; 2002 May; 114(4):361-9. PubMed ID: 11992558
[TBL] [Abstract][Full Text] [Related]
6. Association studies of MAO-A, COMT, and 5-HTT genes polymorphisms in patients with anxiety disorders of the phobic spectrum.
Samochowiec J; Hajduk A; Samochowiec A; Horodnicki J; Stepień G; Grzywacz A; Kucharska-Mazur J
Psychiatry Res; 2004 Aug; 128(1):21-6. PubMed ID: 15450911
[TBL] [Abstract][Full Text] [Related]
7. Case-control study of dopamine transporter-1, monoamine oxidase-B, and catechol-O-methyl transferase polymorphisms in Parkinson's disease.
Goudreau JL; Maraganore DM; Farrer MJ; Lesnick TG; Singleton AB; Bower JH; Hardy JA; Rocca WA
Mov Disord; 2002 Nov; 17(6):1305-11. PubMed ID: 12465073
[TBL] [Abstract][Full Text] [Related]
8. [Predictors of prophylactic response to lithium].
Rohayem J; Baylé JF; Richa S
Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms of dopamine degradation enzyme (COMT and MAO) genes and tardive dyskinesia in patients with schizophrenia.
Matsumoto C; Shinkai T; Hori H; Ohmori O; Nakamura J
Psychiatry Res; 2004 Jun; 127(1-2):1-7. PubMed ID: 15261699
[TBL] [Abstract][Full Text] [Related]
10. Genetic features of antidepressant induced mania and hypo-mania in bipolar disorder.
Serretti A; Artioli P; Zanardi R; Lorenzi C; Rossini D; Cusin C; Arnoldi A; Catalano M
Psychopharmacology (Berl); 2004 Aug; 174(4):504-11. PubMed ID: 15248044
[TBL] [Abstract][Full Text] [Related]
11. The effect of monoamine oxidase B (MAOB) and catechol-O-methyltransferase (COMT) polymorphisms on levodopa therapy in patients with sporadic Parkinson's disease.
Białecka M; Droździk M; Kłodowska-Duda G; Honczarenko K; Gawrońska-Szklarz B; Opala G; Stankiewicz J
Acta Neurol Scand; 2004 Oct; 110(4):260-6. PubMed ID: 15355491
[TBL] [Abstract][Full Text] [Related]
12. The development of peripartum depressive symptoms is associated with gene polymorphisms of MAOA, 5-HTT and COMT.
Doornbos B; Dijck-Brouwer DA; Kema IP; Tanke MA; van Goor SA; Muskiet FA; Korf J
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1250-4. PubMed ID: 19625011
[TBL] [Abstract][Full Text] [Related]
13. Classifying mood disorders by age-at-onset instead of polarity.
Benazzi F
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):86-93. PubMed ID: 18992784
[TBL] [Abstract][Full Text] [Related]
14. Serotonin transporter gene associated with lithium prophylaxis in mood disorders.
Serretti A; Lilli R; Mandelli L; Lorenzi C; Smeraldi E
Pharmacogenomics J; 2001; 1(1):71-7. PubMed ID: 11913731
[TBL] [Abstract][Full Text] [Related]
15. Association study of monoamine oxidase and catechol-O-methyltransferase genes with smoking behavior.
Tochigi M; Suzuki K; Kato C; Otowa T; Hibino H; Umekage T; Kato N; Sasaki T
Pharmacogenet Genomics; 2007 Oct; 17(10):867-72. PubMed ID: 17885625
[TBL] [Abstract][Full Text] [Related]
16. Gene-gene interaction between MAOA and COMT in suicidal behavior: analysis in schizophrenia.
De Luca V; Tharmalingam S; Müller DJ; Wong G; de Bartolomeis A; Kennedy JL
Brain Res; 2006 Jun; 1097(1):26-30. PubMed ID: 16725119
[TBL] [Abstract][Full Text] [Related]
17. Catechol-O-methyltransferase (COMT) gene variants predict response to bupropion therapy for tobacco dependence.
Berrettini WH; Wileyto EP; Epstein L; Restine S; Hawk L; Shields P; Niaura R; Lerman C
Biol Psychiatry; 2007 Jan; 61(1):111-8. PubMed ID: 16876132
[TBL] [Abstract][Full Text] [Related]
18. Schizophrenia and functional polymorphisms in the MAOA and COMT genes: no evidence for association or epistasis.
Norton N; Kirov G; Zammit S; Jones G; Jones S; Owen R; Krawczak M; Williams NM; O'Donovan MC; Owen MJ
Am J Med Genet; 2002 Jul; 114(5):491-6. PubMed ID: 12116182
[TBL] [Abstract][Full Text] [Related]
19. Analysis of polymorphisms in the alpha-subunit of the olfactory G-protein Golf in lithium-treated bipolar patients.
Zill P; Malitas PN; Bondy B; Engel R; Boufidou F; Behrens S; Alevizos BE; Nikolaou CK; Christodoulou GN
Psychiatr Genet; 2003 Jun; 13(2):65-9. PubMed ID: 12782961
[TBL] [Abstract][Full Text] [Related]
20. Lithium in the long-term treatment of bipolar disorders.
Kleindienst N; Greil W
Eur Arch Psychiatry Clin Neurosci; 2003 Jun; 253(3):120-5. PubMed ID: 12904975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
